Myofibroblasts are important sources of MMPs in breast cancer, and tumour progression and adverse reactions are associated with strong expression of MMP-1, MMP-7, and MMP-9, as well as fibroblast-specific production of MMP-9, MMP-11, and MMP-1431. Here, MMP9 is linked to neoplasm.